miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients.

Rodríguez-Antolín, Carlos; Felguera-Selas, Laura; Pernía, Olga; Vera, Olga; Esteban, Isabel; Losantos García, Itsaso; de Castro, Javier; Rosas-Alonso, Rocío; Ibanez de Caceres, Inmaculada

Rodríguez-Antolín, Carlos; Felguera-Selas, Laura; Pernía, Olga; Vera, Olga; Esteban, Isabel; Losantos García, Itsaso; de Castro, Javier; Rosas-Alonso, Rocío; Ibanez de Caceres, Inmaculada.

Afiliação

Rodríguez-Antolín C; 1Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain.
Felguera-Selas L; 2Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.
Pernía O; 1Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain.
Vera O; 2Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.
Esteban I; 1Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain.
Losantos García I; 2Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.
de Castro J; 1Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain.
Rosas-Alonso R; 2Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.
Ibanez de Caceres I; 2Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.

Cell Biosci ; 9: 63, 2019.

Article em En | MEDLINE | ID: mdl-31406565

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Cell Biosci Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google